Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Lung Cancer

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Respir Crit Care Med
1 Ann Oncol
1 BMC Cancer
1 Cancer
3 Cancer Lett
2 Cancer Sci
1 Chest
1 Clin Cancer Res
1 Clin Lung Cancer
2 Eur J Cancer
1 Eur Respir J
1 Int J Radiat Oncol Biol Phys
1 J Surg Oncol
3 J Thorac Oncol
1 Lancet
7 Lung Cancer
1 Mol Carcinog
1 PLoS Comput Biol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. ONISHI Y, Kusumoto M, Motoi N, Watanabe H, et al
    Ciliated Muconodular Papillary Tumor of the Lung: Thin-Section CT Findings of 16 Cases.
    AJR Am J Roentgenol. 2020 Jan 22:1-5. doi: 10.2214/AJR.19.21945.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  2. MARTINEZ-ZAYAS G, Almeida FA, Simoff MJ, Yarmus L, et al
    A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.
    Am J Respir Crit Care Med. 2020;201:212-223.
    PubMed         Abstract available

    Ann Oncol

  3. MOK T, Camidge DR, Gadgeel SM, Rosell R, et al
    TEMPORARY REMOVAL: Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.
    Ann Oncol. 2020 May 11. pii: S0923-7534(20)39796.
    PubMed         Abstract available

    BMC Cancer

  4. DE MOL M, Visser S, Aerts J, Lodder P, et al
    The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    BMC Cancer. 2020;20:431.
    PubMed         Abstract available


  5. HADDAD R, Concha-Benavente F, Blumenschein G Jr, Fayette J, et al
    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190.
    PubMed         Abstract available

    Cancer Lett

  6. YANG YF, Wang YY, Hsiao M, Lo S, et al
    IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30227.
    PubMed         Abstract available

  7. ZHAO Z, Zhang N, Li A, Zhou B, et al
    Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30199.
    PubMed         Abstract available

  8. GALLAND S, Martin P, Fregni G, Letovanec I, et al
    Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
    Cancer Lett. 2020;484:50-64.
    PubMed         Abstract available

    Cancer Sci

  9. OTSUBO K, Iwama E, Ijichi K, Kubo N, et al
    Paired genetic analysis by next-generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis.
    Cancer Sci. 2020 May 19. doi: 10.1111/cas.14488.
    PubMed         Abstract available

  10. UDAGAWA H, Kirita K, Naito T, Nomura S, et al
    Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: prospective single-arm study.
    Cancer Sci. 2020 May 19. doi: 10.1111/cas.14489.
    PubMed         Abstract available


  11. PERROTTA F, Nankivell M, Adizie B, Maqsood U, et al
    Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing In Non-Small Cell Lung Cancer.
    Chest. 2020 May 16. pii: S0012-3692(20)31410-0. doi: 10.1016/j.chest.2020.
    PubMed         Abstract available

    Clin Cancer Res

  12. LIU B, Ricarte-Filho J, Mallisetty A, Villani C, et al
    Detection of promoter DNA methylation in urine and plasma aids the detection of non-small cell lung cancer.
    Clin Cancer Res. 2020 May 19. pii: 1078-0432.CCR-19-2896.
    PubMed         Abstract available

    Clin Lung Cancer

  13. SHEN E, Xiu J, Bentley R, Lopez GY, et al
    Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Clin Lung Cancer. 2020 Apr 15. pii: S1525-7304(20)30101.
    PubMed         Abstract available

    Eur J Cancer

  14. IMANISHI M, Yamamoto Y, Hamano Y, Yamada T, et al
    Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score-matched analysis.
    Eur J Cancer. 2018;106:69-77.
    PubMed         Abstract available

  15. SCHWARTZ S, Szeto C, Tian Y, Cecchi F, et al
    Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
    Eur J Cancer. 2018;107:164-174.
    PubMed         Abstract available

    Eur Respir J

  16. RASKIN J, Lebeer M, De Bondt C, Wener R, et al
    Cancer in the time of COVID-19: expert opinion on how to adapt current practice.
    Eur Respir J. 2020;55.

    Int J Radiat Oncol Biol Phys

  17. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.

    J Surg Oncol

  18. XU E, David EA, Ding L, Atay SM, et al
    Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer.
    J Surg Oncol. 2020 May 20. doi: 10.1002/jso.25937.
    PubMed         Abstract available

    J Thorac Oncol

  19. AL-SAMKARI H, Leiva O, Dagogo-Jack I, Shaw A, et al
    Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2020 May 10. pii: S1556-0864(20)30380.
    PubMed         Abstract available

  20. DINGEMANS AC, Soo RA, Jazieh AR, Rice SJ, et al
    Treatment guidance for lung cancer patients during the COVID-19 pandemic.
    J Thorac Oncol. 2020 May 13. pii: S1556-0864(20)30382.
    PubMed         Abstract available

  21. MANJUNATH Y, Mitchem JB, Suvilesh KN, Avella DM, et al
    Circulating giant tumor-macrophage fusion cells are independent prognosticators in non-small cell lung cancer patients.
    J Thorac Oncol. 2020 May 13. pii: S1556-0864(20)30381.
    PubMed         Abstract available


  22. HARRIS DA, Willis J, Tomann M
    A new era of coal workers' pneumoconiosis: decades in mines may not be required.
    Lancet. 2020;395:e82.

    Lung Cancer

  23. PERTEJO-FERNANDEZ A, Ricciuti B, Hammond SP, Marty FM, et al
    Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection.
    Lung Cancer. 2020 Feb 24. pii: S0169-5002(20)30310.
    PubMed         Abstract available

  24. DREVET G, Duruisseaux M, Lafitte C, Derberne M, et al
    A reply to "A comment on "Lung cancer surgical treatment after solid organ transplantation: a single center 30-year experience".
    Lung Cancer. 2020 May 6. pii: S0169-5002(20)30406.

  25. QUIST M, Langer SW, Lillelund C, Winther L, et al
    Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: A randomized clinical trial.
    Lung Cancer. 2020;145:76-82.
    PubMed         Abstract available

  26. ROSSI D
    Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.
    Lung Cancer. 2020;145:83-84.
    PubMed         Abstract available

  27. DALL'OLIO FG, Maggio I, Massucci M, Mollica V, et al
    ECOG performance status >/=2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world data.
    Lung Cancer. 2020;145:95-104.
    PubMed         Abstract available

  28. MORGENSZTERN D, Johnson M, Rudin CM, Rossi M, et al
    SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.
    Lung Cancer. 2020;145:126-131.
    PubMed         Abstract available

  29. ISAKA T, Ito H, Nakayama H, Yokose T, et al
    Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.
    Lung Cancer. 2020;145:111-118.
    PubMed         Abstract available

    Mol Carcinog

  30. XU L, Xu F, Kong Q, Yang T, et al
    Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Mol Carcinog. 2020 May 19. doi: 10.1002/mc.23215.
    PubMed         Abstract available

    PLoS Comput Biol

  31. KONG C, Yao YX, Bing ZT, Guo BH, et al
    Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.
    PLoS Comput Biol. 2020;16:e1007793.
    PubMed         Abstract available

    PLoS One

  32. BARR MP, Gray SG, Hoffmann AC, Hilger RA, et al
    Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
    PLoS One. 2020;15:e0233739.
    PubMed         Abstract available

  33. MIN KW, Kim WS, Kim DH, Son BK, et al
    High polymerase epsilon expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer.
    PLoS One. 2020;15:e0233066.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.